New treatment option for Diabetes Mellitus, Type 2
Official title Home-based Heat Therapy for Type 2 Diabetes
ClinicalTrials.gov ID: NCT05269589
What this study is testing
- What it's testing
- Insulin resistance and hyperglycemia predispose individuals with type 2 diabetes mellitus (T2DM) to endothelial dysfunction and a greater risk of cardiovascular diseases (CVD). Increased CVD risk in individuals with T2DM persists despite optimal pharmacological therapy, highlighting the need to identify complementary lifestyle interventions that improve cardiometabolic functions in this population.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 45 to 75
You may be able to join if
- Age 45-75 years
- Diagnosis of type 2 diabetes mellitus ≥1 year
- Stable medication ≥12 weeks
You likely can't join if
- Class 3 obesity
- Hypertension not controled by medication
- Diagnosis of cardiac, renal and/or pulmonary disease
- Diagnosis of severe neuropathy and/or retinopathy
- Insulin therapy
- Fasting plasma triglycerides \>5.0 mmol/L
See the full eligibility criteria
- Age 45-75 years
- Diagnosis of type 2 diabetes mellitus ≥1 year
- Stable medication ≥12 weeks
- Class 3 obesity
- Hypertension not controled by medication
- Diagnosis of cardiac, renal and/or pulmonary disease
- Diagnosis of severe neuropathy and/or retinopathy
- Insulin therapy
- Fasting plasma triglycerides \>5.0 mmol/L
- Fasting total cholesterol \>7 mmol/l
The study team makes the final eligibility decision.
Where it's taking place
- Montreal, Quebec, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 45 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Montreal, Quebec, Canada. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.